PPA
TMCI icon

Parametric Portfolio Associates’s Treace Medical Concepts TMCI Stock Holding History

Parametric Portfolio Associates’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$298K Buy
15,781
+5,699
+57% +$111K ﹤0.01% 3282
2021
Q4 		$188K Sell
10,082
-6,585
-40% -$136K ﹤0.01% 3438
2021
Q3 		$448K Sell
16,667
-65
-0.4% -$1.79K ﹤0.01% 3149
2021
Q2 		$523K Buy
+16,732
New +$533K ﹤0.01% 3067

Other funds holding TMCI

AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.89B AUM 151.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Parametric Portfolio Associates's TMCI Position: Q1 2022 in Review

Parametric Portfolio Associates increased its Treace Medical Concepts (TMCI) stake by 57% in Q1 2022, buying an estimated $111K and bringing the position to 15,781 shares worth $298K. The position accounts for ﹤0.01% of the portfolio, ranked #3282.

Parametric Portfolio Associates first reported a position in TMCI in Q2 2021 and has held it in 4 quarters since. The position peaked at $523K in Q2 2021. 76 funds tracked by Wall St. Rank hold TMCI as of Q1 2022.

  • Parametric Portfolio Associates held 15,781 shares of Treace Medical Concepts worth $298K as of Q1 2022.
  • Parametric Portfolio Associates bought 5,699 Treace Medical Concepts shares in Q1 2022, an estimated $111K.
  • Treace Medical Concepts made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3282 holding.
  • Parametric Portfolio Associates first reported a position in Treace Medical Concepts in Q2 2021 and has held it in 4 quarters since.
  • Parametric Portfolio Associates's Treace Medical Concepts position peaked at $523K in Q2 2021.
  • 76 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.